These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 24226057)

  • 1. Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.
    Luetkemeyer AF; Kendall MA; Nyirenda M; Wu X; Ive P; Benson CA; Andersen JW; Swindells S; Sanne IM; Havlir DV; Kumwenda J;
    J Acquir Immune Defic Syndr; 2014 Apr; 65(4):423-8. PubMed ID: 24226057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.
    Naidoo K; Yende-Zuma N; Padayatchi N; Naidoo K; Jithoo N; Nair G; Bamber S; Gengiah S; El-Sadr WM; Friedland G; Abdool Karim S
    Ann Intern Med; 2012 Sep; 157(5):313-24. PubMed ID: 22944873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.
    Laureillard D; Marcy O; Madec Y; Chea S; Chan S; Borand L; Fernandez M; Prak N; Kim C; Dim B; Nerrienet E; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX;
    AIDS; 2013 Oct; 27(16):2577-86. PubMed ID: 24096631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome.
    Conesa-Botella A; Meintjes G; Coussens AK; van der Plas H; Goliath R; Schutz C; Moreno-Reyes R; Mehta M; Martineau AR; Wilkinson RJ; Colebunders R; Wilkinson KA
    Clin Infect Dis; 2012 Oct; 55(7):1004-11. PubMed ID: 22715179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TB.
    Haridas V; Pean P; Jasenosky LD; Madec Y; Laureillard D; Sok T; Sath S; Borand L; Marcy O; Chan S; Tsitsikov E; Delfraissy JF; Blanc FX; Goldfeld AE;
    AIDS; 2015 Jan; 29(3):263-73. PubMed ID: 25486415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.
    Havlir DV; Kendall MA; Ive P; Kumwenda J; Swindells S; Qasba SS; Luetkemeyer AF; Hogg E; Rooney JF; Wu X; Hosseinipour MC; Lalloo U; Veloso VG; Some FF; Kumarasamy N; Padayatchi N; Santos BR; Reid S; Hakim J; Mohapi L; Mugyenyi P; Sanchez J; Lama JR; Pape JW; Sanchez A; Asmelash A; Moko E; Sawe F; Andersen J; Sanne I;
    N Engl J Med; 2011 Oct; 365(16):1482-91. PubMed ID: 22010914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
    Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
    Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection.
    Worodria W; Menten J; Massinga-Loembe M; Mazakpwe D; Bagenda D; Koole O; Mayanja-Kizza H; Kestens L; Mugerwa R; Reiss P; Colebunders R;
    Antivir Ther; 2012; 17(5):841-8. PubMed ID: 22543224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and pattern of tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in patients on anti-retroviral therapy: An observational study.
    Nayak B; Panda RK; Mohanty T; Sahu L
    Indian J Tuberc; 2024 Jul; 71(3):291-296. PubMed ID: 39111937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients.
    Breton G; Bourgarit A; Pavy S; Bonnet D; Martinez V; Duval X; Longuet P; Abgrall S; Simon A; Leport C;
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1365-70. PubMed ID: 23107635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil Activation and Enhanced Release of Granule Products in HIV-TB Immune Reconstitution Inflammatory Syndrome.
    Nakiwala JK; Walker NF; Diedrich CR; Worodria W; Meintjes G; Wilkinson RJ; Mayanja-Kizza H; Colebunders R; Kestens L; Wilkinson KA; Lowe DM
    J Acquir Immune Defic Syndr; 2018 Feb; 77(2):221-229. PubMed ID: 29135655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study.
    Yang CH; Chen KJ; Tsai JJ; Lin YH; Cheng SH; Wang KF; Chiou HY
    BMC Infect Dis; 2014 Jun; 14():304. PubMed ID: 24897928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunopathogenesis of the HIV tuberculosis immune reconstitution inflammatory syndrome.
    Lai RP; Nakiwala JK; Meintjes G; Wilkinson RJ
    Eur J Immunol; 2013 Aug; 43(8):1995-2002. PubMed ID: 23928963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of antiretroviral therapy with tuberculosis treatment.
    Abdool Karim SS; Naidoo K; Grobler A; Padayatchi N; Baxter C; Gray AL; Gengiah T; Gengiah S; Naidoo A; Jithoo N; Nair G; El-Sadr WM; Friedland G; Abdool Karim Q
    N Engl J Med; 2011 Oct; 365(16):1492-501. PubMed ID: 22010915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and risk factors of paradoxical tuberculosis associated immune reconstitution inflammatory syndrome among HIV-infected patients in Beijing, China.
    Xue M; Xie R; Pang Y; Yan S; Du Y; Guan C; Chen B
    BMC Infect Dis; 2020 Jul; 20(1):554. PubMed ID: 32736608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.
    Meintjes G; Stek C; Blumenthal L; Thienemann F; Schutz C; Buyze J; Ravinetto R; van Loen H; Nair A; Jackson A; Colebunders R; Maartens G; Wilkinson RJ; Lynen L;
    N Engl J Med; 2018 Nov; 379(20):1915-1925. PubMed ID: 30428290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome.
    Conesa-Botella A; Loembé MM; Manabe YC; Worodria W; Mazakpwe D; Luzinda K; Mayanja-Kizza H; Miri M; Mbabazi O; Koole O; Kestens L; Colebunders R;
    J Acquir Immune Defic Syndr; 2011 Dec; 58(5):463-8. PubMed ID: 21963941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis Immune Reconstitution Inflammatory Syndrome in children initiating Antiretroviral Therapy for HIV infection: A systematic literature review.
    Link-Gelles R; Moultrie H; Sawry S; Murdoch D; Van Rie A
    Pediatr Infect Dis J; 2014 May; 33(5):499-503. PubMed ID: 24736441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration and task shifting for TB/HIV care and treatment in highly resource-scarce settings: one size may not fit all.
    Van Rie A; Patel MR; Nana M; Vanden Driessche K; Tabala M; Yotebieng M; Behets F
    J Acquir Immune Defic Syndr; 2014 Mar; 65(3):e110-7. PubMed ID: 24091692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.